极低剂量氢化可的松对脓毒性休克休克逆转的影响
该单中心回顾性队列研究纳入213例因脓毒性休克接受氢化可的松治疗的患者,比较低剂量(75-150 mg/d,41例)与标准剂量(200-400 mg/d,172例)对休克逆转及不良事件的影响。两组基线升压药需求和SOFA评分相似,升压药需求变化率、撤药条件风险率和累积撤药概率在数量上均相似。低剂量组胰岛素需求(尤其糖尿病患者)、糖尿病患者血糖和继发感染频率似乎更低,死亡率和其它次要结局相似。作者认为低剂量氢化可的松逆转休克似乎与标准剂量同样有效,且不良事件可能更少。
要点
- 在脓毒性休克患者中,氢化可的松75-150 mg/d与200-400 mg/d的升压药撤药条件风险率和累积撤药概率在数量上相似。
- 低剂量组(75-150 mg/d)胰岛素需求(尤其糖尿病患者)、糖尿病患者血糖和继发感染频率似乎低于标准剂量组(200-400 mg/d)。
- 两组死亡率和其它次要结局相似。
- 该研究为单中心回顾性队列,低剂量组仅41例,标准剂量组172例,基线升压药需求和SOFA评分相似。
适用人群与场景
- 因脓毒性休克接受氢化可的松治疗的患者,来自单中心医疗ICU。
处置流程与药物剂量
- 低剂量氢化可的松:75-150 mg/d,基于初始处方剂量分组。
- 标准剂量氢化可的松:200-400 mg/d,基于初始处方剂量分组。
研究设计与关键结果
- 研究类型为回顾性队列研究,单中心医疗ICU,纳入213例患者,低剂量组41例,标准剂量组172例。
- 两组基线特征包括初始升压药需求和序贯器官衰竭评估(SOFA)评分相似。
- 升压药需求平均变化率、撤药条件风险率和撤药累积概率在低剂量与标准剂量氢化可的松组间在数量上均相似。
- 低剂量氢化可的松组的胰岛素需求(尤其在糖尿病患者中)、糖尿病患者血糖和继发感染频率似乎更低。
- 死亡率和其它次要结局在两组间相似。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在脓毒性休克中,氢化可的松75-150 mg/d逆转休克似乎与200-400 mg/d同样有效,且可能不良事件频率更低。
- 本研究中心的做法是部分临床医生常规处方低于200 mg/d的剂量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: In patients with septic shock, hydrocortisone 200-400 mg/d has been shown to reverse shock compared with placebo. Lower doses of hydrocortisone have not previously been studied, and there are no previous studies comparing two different doses of hydrocortisone. At our institution, some clinicians routinely prescribe doses less than 200 mg/d. This study aims to compare the effect of lower doses of hydrocortisone to standard doses on shock reversal and adverse events in septic shock.
DESIGN: Retrospective cohort study.
SETTING: Single-center medical ICU.
SUBJECTS: Patients who received hydrocortisone for septic shock.
INTERVENTIONS: Electronic chart review.
MEASUREMENTS AND MAIN RESULTS: Patients were divided into low-dose hydrocortisone (75-150 mg/d) and standard-dose hydrocortisone (200-400 mg/d) cohorts based on initial prescribed hydrocortisone dose. Rates of shock reversal and adverse events in the two cohorts were compared. Two-hundred thirteen patients were included-41 in low-dose and 172 in standard-dose cohorts. Baseline characteristics including initial vasopressor requirement and Sequential Organ Failure Assessment scores were similar. Average rates of change in vasopressor needs, conditional hazard rate for vasopressor withdrawal, and cumulative probability for vasopressor withdrawal were all quantitatively similar for low-dose and standard-dose hydrocortisone. Insulin requirement (particularly in those with diabetes mellitus), blood glucose in those with diabetes mellitus, and frequency of secondary infections seemed to be lower in the low-dose hydrocortisone cohort. Mortality and other secondary outcomes were similar.
CONCLUSIONS: In septic shock, hydrocortisone dosed 75-150 mg/d appears to reverse shock as effectively 200-400 mg/d and may cause a lower frequency of adverse events.
参考来源
- Sbertoli R, Hu Z, Henke J, et al. Effect of Very Low-Dose Hydrocortisone on Shock Reversal in Patients With Septic Shock. Crit Care Explor. 2020. PMID: 32426738. doi:10.1097/CCE.0000000000000096
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。